UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

859 Skin tape strip proteomics in mycosis fungoides identifies tumor associated biomarkers

Journal of investigative dermatology, 2022-08, Vol.142 (8), p.S149

2022

Volltextzugriff (PDF)

629 PLGA-immune modifying particles as a potential therapy for treating injured skin

Journal of investigative dermatology, 2021-05, Vol.141 (5), p.S109

2021

Volltextzugriff (PDF)

839 Early biomarker identification for immune sensitization and prevention with oral vitamin D3

Journal of investigative dermatology, 2022-08, Vol.142 (8), p.S145

2022

Volltextzugriff (PDF)

439 Oral 25-hydroxyvitamin D3 reduces chemical-induced skin inflammation in humans

Journal of investigative dermatology, 2021-05, Vol.141 (5), p.S76

2021

Volltextzugriff (PDF)

488 Synthetic melanin nanoparticles as a potential topical therapy for treating injured skin

Journal of investigative dermatology, 2021-05, Vol.141 (5), p.S84

2021

Volltextzugriff (PDF)

Spillover of Sorbed Species

Advances in Catalysis, 1986, Vol.34, p.1-79

1986

Volltextzugriff (PDF)

Skin Tape Strip Proteomics in Mycosis Fungoides Identifies Tumor-Associated Biomarkers

Journal of investigative dermatology, 2023-03, Vol.143 (3), p.517-520.e12

2023

Volltextzugriff (PDF)

Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter Randomized Placebo-Controlled Trial

European urology, 2014-08, Vol.66 (2), p.265-272

2014

Volltextzugriff (PDF)

Phase III Trial of Alvimopan, a Novel, Peripherally Acting, Mu Opioid Antagonist, for Postoperative Ileus After Major Abdominal Surgery

Diseases of the colon & rectum, 2005-06, Vol.48 (6), p.1114-1129

2005

Volltextzugriff (PDF)

Gastrointestinal recovery after laparoscopic colectomy: results of a prospective, observational, multicenter study

Surgical endoscopy, 2010-03, Vol.24 (3), p.653-661

2010

Volltextzugriff (PDF)

Economic analysis of alvimopan in North American Phase III efficacy trials

American journal of health-system pharmacy, 2009-08, Vol.66 (15), p.1362-1368

2009

Volltextzugriff (PDF)

The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor

Pharmacology & therapeutics (Oxford), 2008-01, Vol.117 (1), p.162-187

2008

Volltextzugriff (PDF)

Alvimopan, a Peripherally Acting μ-Opioid Receptor Antagonist, is Associated with Reduced Costs after Radical Cystectomy: Economic Analysis of a Phase 4 Randomized, Controlled Trial

The Journal of urology, 2014-06, Vol.191 (6), p.1721-1727

2014

Volltextzugriff (PDF)

Alvimopan: An oral, peripherally acting, μ-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction—A 21-day treatment-randomized clinical trial

The journal of pain, 2005-03, Vol.6 (3), p.184-192

2005

Volltextzugriff (PDF)

Alvimopan, for postoperative ileus following bowel resection : A pooled analysis of phase III studies

Annals of surgery, 2007-03, Vol.245 (3), p.355-363

2007

Volltextzugriff (PDF)

Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection: pooled analysis of placebo data from 3 randomized controlled trials

The American journal of surgery, 2006-03, Vol.191 (3), p.315-319

2006

Volltextzugriff (PDF)

Evaluation of Clinical Outcomes With Alvimopan in Clinical Practice: A National Matched-Cohort Study in Patients Undergoing Bowel Resection

Annals of surgery, 2012-04, Vol.255 (4), p.731-738

2012

Volltextzugriff (PDF)

Postoperative Ileus-Related Morbidity Profile in Patients Treated with Alvimopan after Bowel Resection

Journal of the American College of Surgeons, 2007-04, Vol.204 (4), p.609-616

2007

Volltextzugriff (PDF)

Alvimopan accelerates gastrointestinal recovery after bowel resection regardless of age, gender, race, or concomitant medication use

Surgery, 2007-10, Vol.142 (4), p.478-486

2007

Volltextzugriff (PDF)

Effect of alvimopan (ALV) on gastrointestinal (GI) recovery, length of hospital stay (LOS), and postoperative ileus (POI)-related morbidity in patients (PTS) undergoing bowel resection (BR) for colon or rectal cancer (CRC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.4014-4014

2007

Volltextzugriff (PDF)

Economic Analysis of Alvimopan-A Clarification and Commentary

Pharmacotherapy, 2013-05, Vol.33 (5), p.e81-e82

2013

Volltextzugriff (PDF)

A double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomy

American journal of obstetrics and gynecology, 2006-08, Vol.195 (2), p.445-453

2006

Volltextzugriff (PDF)

Changes in the flexibility characteristics of the ankle complex due to damage to the lateral collateral ligaments: An in vitro and in vivo study

Journal of orthopaedic research, 1997-05, Vol.15 (3), p.331-341

1997

Volltextzugriff (PDF)

Impact of alvimopan (entereg) on hospital costs after bowel resection: results from a large inpatient database

P&T (Lawrenceville, N.J.), 2011-04, Vol.36 (4), p.209-220

2011

Volltextzugriff (PDF)

763

The journal of pain, 2006-04, Vol.7 (4), p.S42

2006

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(32)
Tagungsberichte
(1)

Sprache

Englisch
(33)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(19)
Science & Technology
(19)
Life Sciences & Biomedicine
(17)
Female
(11)
Male
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Middle Aged
(10)
Piperidines - Therapeutic Use
(9)
Alvimopan
(8)
Surgery
(7)
Aged
(6)
Gastrointestinal Agents - Therapeutic Use
(6)
Receptors, Opioid, Mu - Antagonists & Inhibitors
(6)
Double-Blind Method
(5)
General Aspects
(5)
Ileus
(5)
Ileus - Prevention & Control
(5)
Postoperative Complications - Prevention & Control
(5)
Adult
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

859 Skin tape strip proteomics in mycosis fungoides identifies tumor associated biomarkers

629 PLGA-immune modifying particles as a potential therapy for treating injured skin

839 Early biomarker identification for immune sensitization and prevention with oral vitamin D3

439 Oral 25-hydroxyvitamin D3 reduces chemical-induced skin inflammation in humans

488 Synthetic melanin nanoparticles as a potential topical therapy for treating injured skin

Spillover of Sorbed Species

Skin Tape Strip Proteomics in Mycosis Fungoides Identifies Tumor-Associated Biomarkers

Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter Randomized Placebo-Controlled Trial

Phase III Trial of Alvimopan, a Novel, Peripherally Acting, Mu Opioid Antagonist, for Postoperative Ileus After Major Abdominal Surgery

Gastrointestinal recovery after laparoscopic colectomy: results of a prospective, observational, multicenter study

Economic analysis of alvimopan in North American Phase III efficacy trials

The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor

Alvimopan, a Peripherally Acting μ-Opioid Receptor Antagonist, is Associated with Reduced Costs after Radical Cystectomy: Economic Analysis of a Phase 4 Randomized, Controlled Trial

Alvimopan: An oral, peripherally acting, μ-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction—A 21-day treatment-randomized clinical trial

Alvimopan, for postoperative ileus following bowel resection : A pooled analysis of phase III studies

Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection: pooled analysis of placebo data from 3 randomized controlled trials

Evaluation of Clinical Outcomes With Alvimopan in Clinical Practice: A National Matched-Cohort Study in Patients Undergoing Bowel Resection

Postoperative Ileus-Related Morbidity Profile in Patients Treated with Alvimopan after Bowel Resection

Alvimopan accelerates gastrointestinal recovery after bowel resection regardless of age, gender, race, or concomitant medication use

Effect of alvimopan (ALV) on gastrointestinal (GI) recovery, length of hospital stay (LOS), and postoperative ileus (POI)-related morbidity in patients (PTS) undergoing bowel resection (BR) for colon or rectal cancer (CRC)

Economic Analysis of Alvimopan-A Clarification and Commentary

A double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomy

Changes in the flexibility characteristics of the ankle complex due to damage to the lateral collateral ligaments: An in vitro and in vivo study

Impact of alvimopan (entereg) on hospital costs after bowel resection: results from a large inpatient database

763

Suchergebnisse filtern